Aurobindo Pharma shines on getting USFDA’s nod for Entecavir Tablets

28 Aug 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 774.10, up by 30.20 points or 4.06% from its previous closing of Rs. 743.90 on the BSE.

The scrip opened at Rs. 756.90 and has touched a high and low of Rs. 778.50 and Rs. 752.50 respectively. So far 126695 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 832.50 on 20-Aug-2015 and a 52 week low of Rs. 382.50 on 24-Sep-2014.

Last one week high and low of the scrip stood at Rs. 814.95 and Rs. 646.20 respectively. The current market cap of the company is Rs. 45198.86 crore.

The promoters holding in the company stood at 53.92% while Institutions and Non-Institutions held 35.75% and 10.33% respectively.

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg. The approved Abbreviated New Drug Application (ANDA) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Baraclude Tablets, 0.5mg and 1mg, of Bristol-Myers Squibb.

Entecavir Tablets are indicated for treatment of chronic hepatitis B virus infection of the liver. The product has an estimated market size of $294 million for the twelve months ending June 2015.

This is the 44th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products. Aurobindo now has a total of 209 ANDA approvals (181 Final approvals including 9 from Aurolife Pharma LLC and 28 Tentative approvals) from USFDA.

 

Aurobindo Pharma Share Price

1276.35 -15.05 (-1.17%)
23-Mar-2026 13:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1767.25
Dr. Reddys Lab 1273.05
Cipla 1235.40
Zydus Lifesciences 871.15
Lupin 2302.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×